New diabetes clinical trial: A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Published on: November 06, 2019 at 10:30PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: BI 456906;   Drug: Placebo;   Drug: Semaglutide
Sponsor:   Boehringer Ingelheim
Not yet recruiting
https://ift.tt/2Cl5WNz